2026-01-13 - Analysis Report
**Company Overview**
Intuitive Surgical Inc, a medical device company that develops and manufactures robotic surgical systems.

**Return Rate Comparison**
Return Rate (rate) of ISRG: 81.96%
Return Rate (rate_vs) of VOO (S&P 500): 94.34%
Degree of divergence (difference in cumulative return on the last day of the data): -12.38%

**Alpha, Beta Analysis**
| Year | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | 49.0% | 29.0% | 45.0% | 1.2 | 57.2B |
| 2017-2019 | 40.0% | 29.0% | 23.0% | 1.4 | 70.6B |
| 2018-2020 | -8.0% | 29.0% | -29.0% | 1.2 | 97.8B |
| 2019-2021 | 26.0% | 21.1% | -17.0% | 1.2 | 128.8B |
| 2020-2022 | -18.0% | 48.9% | -16.0% | 1.2 | 95.1B |
| 2021-2023 | -12.0% | 48.9% | -13.0% | 1.4 | 120.9B |
| 2022-2024 | 35.0% | 38.0% | 16.0% | 1.3 | 187.1B |
| 2023-2025 | 60.0% | 28.0% | -2.0% | 1.2 | 203.0B |

**Recent Stock Price Fluctuations**
Close: $572.74
Last-market price: $572.74, Previous close: $586.24, Change: -2.3%
5-day SMA: $585.84
20-day SMA: $571.59
60-day SMA: $554.61
**Note:** Recent sharp decline in stock price, reflecting a fluctuation issue.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**
Market Risk Indicator (MRI): 0.80 (Indicating high investment recommended at this time)
RSI: 50.17
PPO: -0.01
Hybrid Signal: Buy (Cash 0%); Risk Level: Medium (MRI 0.80); Recent relative divergence change: 3.80 (+) improving
7-day Rank change: 5 (+) rank up; 7-day Dynamic Expected Return change: -0.50 (-) worsening

**Expected Return**
Expected Return: 3.80%
Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

**Recent News & Significant Events**
Multiple recent news headlines suggest that investors are questioning whether the strong multi-year share price run has gone too far, with some suggesting it may be too late to consider the stock. Other headlines highlight AI catalysts ahead for Intuitive Surgical, which has seen a 40% gain in recent times.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): 608.26 / 740.00 / 378.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|-----|----|--------|
| 2025-10-22 | 1.98 | 2.51B$ |
| 2025-07-23 | 1.84 | 2.44B$ |
| 2025-04-23 | 1.95 | 2.25B$ |
| 2024-10-18 | 1.59 | 2.04B$ |
| 2025-10-22 | 1.59 | 2.04B$ |
The quarterly earnings data suggests a slight decrease in revenue for FY2025 compared to FY2024, but an increase in earnings per share. This may indicate a positive trend for the company's future growth.

**Financial Information**
**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
**Note:** Revenue has shown a slight decrease in FY2025 compared to FY2024, but profit margin remains relatively stable.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
**Note:** The company's equity and return on equity (ROE) have shown a relatively stable trajectory over the past year.

**Comprehensive Analysis**
Intuitive Surgical Inc has shown a strong multi-year share price run, with a 40% gain in recent times. The company's financial performance has been relatively stable, with a slight decrease in revenue in FY2025 compared to FY2024. Analysts suggest a buy rating, with a target price of $608.26. However, recent news headlines question whether the strong run has gone too far, and the company's recent sharp decline in stock price reflects a fluctuation issue. The company's hybrid signal is buy, and the risk level is medium, with a market risk indicator of 0.80. The expected return is 3.80%, and the expected excess return compared to S&P 500 if invested long-term is also 3.80%.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.